(On homepage) Until recently, proton therapy has occupied a small niche within the field of radiation oncology. Penn Medicine has played a leading role in championing proton therapy and moving the field forward.
(Image: Scott Nibauer)
The power of protons
Penn Medicine has treated more than 10,000 cancer patients at three proton therapy centers across the region, including the largest and busiest center in the world—while also leading the way in research to expand the healing potential of these positive particles.
At a community event held at Irvine Auditorium, West Philadelphia residents were welcomed to receive FIT kits to screen for colon cancer, have their blood pressure taken, and more.
nocred
Decentralizing cancer screenings
A Projects for Progress team in the Abramson Cancer Center continues to work with the West Philadelphia community to bring cancer screenings out of clinical settings.
(On homepage) Renee Jones helps Valerie Simon toward her ultimate recovery goal after a hip replacement: being able to walk to the corner store and cross the street before the light turns red, using a cane rather than a walker.
Home health care—a crucial edge for the future of medicine
Home care has long been a part of health care, but it was the COVID-19 pandemic that led Penn Medicine to rethink who needed to be in the hospital.
Today, Weissman and colleagues are working to develop a pan-coronavirus vaccine capable of protecting the population against SARS, MERS, SARS-CoV-2, and more. At BioNTech, Karikó is overseeing parallel but distinct research on a range of diseases in which patients receive mRNA encoding therapeutic proteins. (Image: Peggy Peterson)
From foundational discoveries to profound impact
How decades of mRNA research at Penn made powerful new COVID-19 vaccines possible—and opened a new vista for future discoveries.
Class of 2019 alumni, in collaboration with Sayre Health Clinic, bring housing and food insecure people in Philadelphia primary care through a medically outfitted van.
For nearly two decades, a major national study of kidney disease led and coordinated at Penn has defined key risk factors in an all-too-common silent epidemic.
A groundbreaking genetic study seeks to transform the prevention and treatment of glaucoma while reversing historical racial disparities in who suffers from the disease, and who benefits from such research.
(On homepage) Renee Jones helps Valerie Simon toward her ultimate recovery goal after a hip replacement: being able to walk to the corner store and cross the street before the light turns red, using a cane rather than a walker.
Today, Weissman and colleagues are working to develop a pan-coronavirus vaccine capable of protecting the population against SARS, MERS, SARS-CoV-2, and more. At BioNTech, Karikó is overseeing parallel but distinct research on a range of diseases in which patients receive mRNA encoding therapeutic proteins. (Image: Peggy Peterson)
